Home > Insider Trading > Filing (0000899243-19-026831)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1552451	Myokardia Inc	MYOK	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1413822	Anastasios Gianakakos	C/O Myokardia Inc. 333 Allerton Avenue South San Francisco CA 94080	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-10-31	44	$40.07	96,514	No	5	A	Direct
Common Stock	Disposition	2019-11-04	5,000	$59.07	91,514	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	A	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	49,473	Indirect	By Reporting Person's Trust 2
Common Stock	500,000	Indirect	By Reporting Person's Trust 3
Common Stock	12,200	Indirect	By Trust 1
Common Stock	12,200	Indirect	By Trust 2
Common Stock	12,200	Indirect	By Trust 3

Footnotes

Shares acquired pursuant to the Issuer's 2013 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Represents the weighted average sale price of the shares sold ranging from $58.71 to $59.47 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.